Market Movers

Albemarle Corporation’s stock price drops to $121.12, marking a 6.01% decrease

Albemarle Corporation (ALB)

121.12 USD -7.75 (-6.01%) Volume: 3.03M

Albemarle Corporation’s stock price stands at 121.12 USD, witnessing a decline of 6.01% in this trading session on a volume of 3.03M shares, extending its YTD performance to -16.17%, reflecting the volatile market conditions.


Latest developments on Albemarle Corporation

Albemarle Corp. has experienced a turbulent week in the stock market, with shares initially underperforming compared to competitors on both Tuesday and Thursday. However, the company’s stock demonstrated resilience, outperforming competitors on a strong trading day. This fluctuation in stock performance comes as JB Capital LLC takes a position in Albemarle Co. (NYSE:ALB) and the company’s former CCO shares insights into the drivers behind their data analytics success at CW2024.


Albemarle Corporation on Smartkarma

Albemarle Corp is a company that is being closely watched by top independent analysts on Smartkarma, an independent investment research network. According to a report by Baptista Research, the company’s 2023 earnings reported a 31% rise in net sales compared to the previous year, with volume growth being a major contributor. The energy storage sector also saw a significant increase in sales. The company’s adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) for the year were $2.8 billion, excluding a lower-cost charge recorded in the fourth quarter.

In another report by Brian Freitas, it was revealed that Albemarle Corp will be added to the VanEck Rare Earth/Strategic Metals Index, replacing ioneer at the close on 15 December. This rebalance is expected to result in a one-way turnover of 13.4% and a one-way trade of US$50 million. The report also mentioned that this move could potentially reduce the weight of mainland China stocks in the index significantly.

However, in a report by Baptista Research, the company’s recent results were deemed a major disappointment as it failed to meet Wall Street’s revenue and earnings expectations. Despite a surge in sales, Albemarle Corp‘s net income saw a significant decline of 66%, amounting to approximately $303 million. The report also highlighted a fundamental analysis of the company’s historical financial statements.


A look at Albemarle Corporation Smart Scores

FactorScoreMagnitude
Value4
Dividend3
Growth5
Resilience3
Momentum3
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Albemarle Corp, a company that specializes in producing chemicals used in various industries, has received high scores in several key areas. According to Smartkarma’s Smart Scores, Albemarle Corp has scored a 4 out of 5 in value, indicating a positive long-term outlook for the company’s financial performance. This is followed by a score of 3 for both dividend and resilience, indicating a stable and reliable company. In addition, Albemarle Corp has also scored a perfect 5 for growth, suggesting potential for future expansion and success. These scores suggest a positive outlook for the company and its ability to thrive in the long-term.

Based on the company’s description, Albemarle Corp is a leader in producing specialty and fine chemicals that are used in various industries such as plastics, cleaning products, and pharmaceuticals. The majority of their products are manufactured in the United States, showcasing their commitment to quality and reliability. With high scores in key areas such as value, growth, and resilience, it is clear that Albemarle Corp is a strong and promising company with a positive long-term outlook. Investors and stakeholders can be confident in the company’s ability to continue to thrive and succeed in the future.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars